Simon
Senior Member
- Messages
- 3,789
- Location
- Monmouth, UK
From the Action for ME 2013 Research Conference & AGM
Stephen Holgate was the keynote speaker and, as usual, was immensely interesting:
He talked about how modern medicine handles simple diseaeses well, but:
He goes on to argue that new technology's capabilities new affordability (the cost of sequencing the human genome has fallen from $23 million 20 years ago [edit: $3 billion!] to under $1,000 now) will help provide the solution. (read more about this A Dozen Different Diseases? Stephen Holgate Calls for Radical Change in ME/CFS Research).
Last year AfME had Julia Newton as its key speaker, this year Stephen Holgate - both pursuing a biomedical research agenda, which I find very encouraging.
Stephen Holgate was the keynote speaker and, as usual, was immensely interesting:
he gave a brief overview of where we have been in the field of M.E./CFS research up to now, and how little contribution it has made to patient benefit. There is hardly an organ of the body not affected by this disease, and yet there is still an enormous lack of knowledge, disagreement over diagnostics, and perceptions of M.E./CFS vary enormously “We are bathing in a bath of ignorance,” said Prof Holgate. “Times have got to change.”
He talked about how modern medicine handles simple diseaeses well, but:
Non-communicable, chronic inflammatory and degenerative conditions, plus the public health crisis caused by increasingly toxic lifestyles, are enormously difficult and expensive to manage and research
He goes on to argue that new technology's capabilities new affordability (the cost of sequencing the human genome has fallen from $23 million 20 years ago [edit: $3 billion!] to under $1,000 now) will help provide the solution. (read more about this A Dozen Different Diseases? Stephen Holgate Calls for Radical Change in ME/CFS Research).
I do like the sound of particpatory.It has led to what is called P4 medicine: personalised, predictive, preventative and participatory.
Last year AfME had Julia Newton as its key speaker, this year Stephen Holgate - both pursuing a biomedical research agenda, which I find very encouraging.
Last edited: